Abstract
The effect of ketanserin, a selective serotonin-2 (5-HT2) receptor blocking agent, on the secretion of anterior pituitary hormones was studied in 4 healthy volunteers. Ketanserin (10 mg) was administered as a slow iv injection and its effect was compared with that of saline. Ketanserin influenced neither the basal plasma levels of HGH, ACTH, TSH, LH or prolactin, nor the plasma levels of T4, T3, Cortisol or glucose. Even if a single dose of ketanserin had no hormonal effects, this must also be studied after long term use.
References
Jacoby J.H., Thomas R.F. Neuroendocrine consequences of chemical indolectomy. Ann. NY Acad. Sci. 305: 387, 1978.
Krulich L. Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Ann. Rev. Physiol. 41: 603, 1979.
Vale W., Rivier C., Brown M. Regulatory peptides of the hypothalamus. Ann. Rev. Physiol. 39: 473, 1977
Tuomisto J. Neuropharmacological intervention on the pituitary-hy-pothalamic relationship. Annu. Clin. Res. 10:120, 1978.
Kordon C., Enjalbert A., Hery M., Joseph-Bravo P.I., Rotsztejn W., Ruberg M. Role of neurotransmitters in the control of adenohy-pophyseal secretion. In: Morgane P.J., Panksepp J. (Eds.), Handbook of the hypothalamus. Marcel Dekker, Inc., New York, 1980, vol. 2, p. 253.
Meltzer H.Y., Simonovic M., Gudelsky G.A. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. Eur. J. Pharmacol. 92: 83, 1983.
Rocco A., De Giorgio G., Buongiomo T., Proietti A., Lucchetti G., Falaschi P. Prolactin response to R 41468, a new specific 5HT-2 antagonist. Neuroendocrinol. Lett. 5: 47, 1983.
Rocco A., Melis G.B., Proietti A., Fruzzetti F., Buongiomo T., Paoletti A.M., Kemeni A., Lucchetti G., Falaschi P. Elect of ketanserin, a specific’5-HT-2 receptor antagonist, on prolactin secretion. J. Endocrinol. Invest. 6 (Suppl. 1): 40, 1983.
Leysen J.E., Awouters F., Kennis L., Laduron P.M., Vandenberk J., Janssen P.A.J. Receptor binding profile of R 41468, a novel antagonist at 5-HT2 receptors. Life Sci. 28:1015, 1981.
Laduron P.M., Janssen P.F.M., Leysen J.E. In vivo binding of (3H) ketanserin on serotonin S2-receptors in rat brain. Eur. J. Pharmacol. 81: 43, 1982.
Peroutka S.J., Snyder S.H. Multiple serotonin receptors: differential binding of (3H) 5-hydroxytryptamine, (3H) lysergic acid diethylamide and (3H) spiroperidol. Mol. Pharmacol. 16: 687, 1979.
Peroutka S.J., Lebovitz R.M., Snyder S.H. Two distinct central serotonin receptors with different physiological functions. Science 212: 827, 1981.
Van Neuten J.M., Janssen P.A.J., Van Beek J., Xhonneux R., Verbeuren T.J., Vanhoutte M.P. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J. Pharmacol. Exp. Ther. 218: 217, 1981.
Kalkman H.O., Timmermans P.B.M.W.M., van Zwieten P.A. Characterization of the antihypertensive properties of ketanserin (R 41 458) in rats. J. Pharmacol. Exp. Ther. 222: 227, 1982.
De Cree J., Verhaegen H., Symoens J. Acute blood-pressure-lowering effect of ketanserin. Lancet 7:1161, 1981.
De Cree J., Leempoels J., De Cock W., Geukens H., Verhaegen H. The antihypertensive effect of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients. Angiology 32:137, 1981.
De Cree J., Leempoels J., Geukens H., De Cock W., Verhaegen H. The antihypertensive effects of ketanserin (R 41468) a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension. Clin. Sci. Mol. Med. 67:473, 1981.
Wenting G., Man in ’t Veld A.J., Woittiez A.J., Boomsa F., Schalenkamp M.A.D.H. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br. Med. J. 284: 537, 1982.
Mattila J. Central regulation of rat thyrotropin secretion by monoamines, GABA and the pineal gland. Dissertation. Helsinki, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gordin, A., Mustajoki, P. & Pelkonen, R. Ketanserin without effects on basal anterior pituitary hormone secretion in healthy subjects. J Endocrinol Invest 8, 73–75 (1985). https://doi.org/10.1007/BF03350647
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350647